HSV-2 suppression to reduce maternal HIV-1 RNA levels during pregnancy and breastfeeding.

Trial Profile

HSV-2 suppression to reduce maternal HIV-1 RNA levels during pregnancy and breastfeeding.

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Jan 2013

At a glance

  • Drugs Valaciclovir (Primary)
  • Indications Herpes simplex virus type 2 infections; HIV-1 infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 27 Jul 2012 Results of an analysis investigating T-cell immune activation presented at the 19th International AIDS Conference.
    • 17 Apr 2012 Additional lead trial centre identified as reported by ClinicalTrials.gov.
    • 06 Dec 2011 Results published in the Journal of Infectious Diseases.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top